• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用自适应 LASSO 进行标记特定的加性风险模型的变量选择。

Variable selection for a mark-specific additive hazards model using the adaptive LASSO.

机构信息

School of Statistics and Data Science, LPMC and KLMDASR, Nankai University, Tianjin, China.

School of Mathematics and Statistics, Central China Normal University, Hubei, China.

出版信息

Stat Methods Med Res. 2021 Sep;30(9):2017-2031. doi: 10.1177/09622802211023957. Epub 2021 Jul 15.

DOI:10.1177/09622802211023957
PMID:34266342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9140222/
Abstract

In HIV vaccine efficacy trials, mark-specific hazards models have important applications and can be used to evaluate the strain-specific vaccine efficacy. Additive hazards models have been widely used in practice, especially when continuous covariates are present. In this article, we conduct variable selection for a mark-specific additive hazards model. The proposed method is based on an estimating equation with the first derivative of the adaptive LASSO penalty function. The asymptotic properties of the resulting estimators are established. The finite sample behavior of the proposed estimators is evaluated through simulation studies, and an application to a dataset from the first HIV vaccine efficacy trial is provided.

摘要

在 HIV 疫苗功效试验中,标记特异性危害模型具有重要的应用,可以用于评估针对特定毒株的疫苗功效。加性危害模型在实践中得到了广泛应用,尤其是在存在连续协变量的情况下。本文针对标记特异性加性危害模型进行变量选择。所提出的方法基于具有自适应 LASSO 惩罚函数一阶导数的估计方程。建立了所得估计量的渐近性质。通过模拟研究评估了所提出的估计量的有限样本性能,并提供了对首个 HIV 疫苗功效试验数据集的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/1e28b2e1624d/nihms-1800539-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/b2a2cbca17d9/nihms-1800539-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/e99ba533cc8e/nihms-1800539-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/73aee1f8a98d/nihms-1800539-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/bdfaab4653d2/nihms-1800539-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/7f6a74101e42/nihms-1800539-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/b6a69ce5f0f2/nihms-1800539-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/1e28b2e1624d/nihms-1800539-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/b2a2cbca17d9/nihms-1800539-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/e99ba533cc8e/nihms-1800539-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/73aee1f8a98d/nihms-1800539-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/bdfaab4653d2/nihms-1800539-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/7f6a74101e42/nihms-1800539-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/b6a69ce5f0f2/nihms-1800539-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2311/9140222/1e28b2e1624d/nihms-1800539-f0007.jpg

相似文献

1
Variable selection for a mark-specific additive hazards model using the adaptive LASSO.使用自适应 LASSO 进行标记特定的加性风险模型的变量选择。
Stat Methods Med Res. 2021 Sep;30(9):2017-2031. doi: 10.1177/09622802211023957. Epub 2021 Jul 15.
2
Mark-specific additive hazards regression with continuous marks.具有连续标记的标记特定相加风险回归。
Lifetime Data Anal. 2017 Jul;23(3):467-494. doi: 10.1007/s10985-016-9369-9. Epub 2016 May 11.
3
Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials.针对存在协变量缺失的分层标记特定比例风险模型的假设检验及其在HIV疫苗疗效试验中的应用。
Biom J. 2018 May;60(3):516-536. doi: 10.1002/bimj.201700002. Epub 2018 Feb 28.
4
Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.带有多元连续标记的标记特异性比例风险模型及其在 HIV 疫苗功效试验中的应用。
Biostatistics. 2013 Jan;14(1):60-74. doi: 10.1093/biostatistics/kxs022. Epub 2012 Jul 3.
5
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.基于连续标记的失效率的双样本问题:在疫苗效力中的应用。
Biostatistics. 2008 Apr;9(2):263-76. doi: 10.1093/biostatistics/kxm028. Epub 2007 Aug 17.
6
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.具有多变量连续标记的标记特异性风险比模型:在疫苗效力中的应用
Biometrics. 2013 Jun;69(2):328-37. doi: 10.1111/biom.12016. Epub 2013 Feb 19.
7
A mark-specific quantile regression model.一种特定标记的分位数回归模型。
Biometrika. 2023 Jun 20;111(1):255-272. doi: 10.1093/biomet/asad039. eCollection 2024 Mar.
8
Additive mixed effect model for recurrent gap time data.用于复发间隔时间数据的加法混合效应模型。
Lifetime Data Anal. 2017 Apr;23(2):223-253. doi: 10.1007/s10985-015-9341-0. Epub 2015 Aug 22.
9
Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.病例队列研究中分组生存数据的加权似然法及其在HIV疫苗试验中的应用
Biometrics. 2008 Dec;64(4):1247-55. doi: 10.1111/j.1541-0420.2008.00998.x.
10
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials.具有缺失标记的分层标记特定比例风险模型中相对失败率的推断及其在HIV疫苗疗效试验中的应用
J R Stat Soc Ser C Appl Stat. 2015 Jan 1;64(1):49-73. doi: 10.1111/rssc.12067.

引用本文的文献

1
A structural MRI marker predicts individual differences in impulsivity and classifies patients with behavioral-variant frontotemporal dementia from matched controls.一种结构磁共振成像标记物可预测冲动性的个体差异,并将行为变异型额颞叶痴呆患者与匹配的对照组区分开来。
bioRxiv. 2024 Sep 16:2024.09.12.612706. doi: 10.1101/2024.09.12.612706.

本文引用的文献

1
Mark-specific additive hazards regression with continuous marks.具有连续标记的标记特定相加风险回归。
Lifetime Data Anal. 2017 Jul;23(3):467-494. doi: 10.1007/s10985-016-9369-9. Epub 2016 May 11.
2
Model selection and inference for censored lifetime medical expenditures.删失寿命期医疗支出的模型选择与推断
Biometrics. 2016 Sep;72(3):731-41. doi: 10.1111/biom.12464. Epub 2015 Dec 21.
3
Shrinkage Estimation of Varying Covariate Effects Based On Quantile Regression.基于分位数回归的可变协变量效应收缩估计
Stat Comput. 2014 Sep 1;24(5):853-869. doi: 10.1007/s11222-013-9406-4.
4
Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.带有多元连续标记的标记特异性比例风险模型及其在 HIV 疫苗功效试验中的应用。
Biostatistics. 2013 Jan;14(1):60-74. doi: 10.1093/biostatistics/kxs022. Epub 2012 Jul 3.
5
Model selection for Cox models with time-varying coefficients.具有时变系数的Cox模型的模型选择
Biometrics. 2012 Jun;68(2):419-28. doi: 10.1111/j.1541-0420.2011.01692.x. Epub 2012 Apr 16.
6
Penalized Estimating Functions and Variable Selection in Semiparametric Regression Models.半参数回归模型中的惩罚估计函数与变量选择
J Am Stat Assoc. 2008 Jun 1;103(482):672-680. doi: 10.1198/016214508000000184.
7
Variable Selection in Nonparametric Varying-Coefficient Models for Analysis of Repeated Measurements.用于重复测量分析的非参数变系数模型中的变量选择
J Am Stat Assoc. 2008 Dec 1;103(484):1556-1569. doi: 10.1198/016214508000000788.
8
PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.具有连续标记的比例风险模型
Ann Stat. 2009 Feb 1;37(1):394-426. doi: 10.1214/07-AOS554.
9
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.基于连续标记的失效率的双样本问题:在疫苗效力中的应用。
Biostatistics. 2008 Apr;9(2):263-76. doi: 10.1093/biostatistics/kxm028. Epub 2007 Aug 17.
10
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.一项用于预防HIV-1感染的重组糖蛋白120疫苗的安慰剂对照3期试验。
J Infect Dis. 2005 Mar 1;191(5):654-65. doi: 10.1086/428404. Epub 2005 Jan 27.